Evidence map›Paper›PMID 42604873›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

Remimazolam vs midazolam for sedation in upper gastrointestinal endoscopy: a systematic review and meta-analysis.

Salma Bahnasy, Ahmad Omar Saleh, Ibrahim A Ababneh, Bishoy Fahim, Tasnim Tarboush, Rovan Aladham, Ismail Elkhattib, Hatem Eltaly, Mohamed Elnaggar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Salma BahnasyMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt. salmanassernasr@gmail.com.
Ahmad Omar SalehMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Ibrahim A AbabnehMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Bishoy FahimMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Tasnim TarboushMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Rovan AladhamMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Ismail ElkhattibMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Hatem EltalyMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.
Mohamed ElnaggarMatruh Specialized Center for Cardiac Surgery and Interventional Catheterization, Marsa Matruh, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remimazolam, an ultra short-acting benzodiazepine with a rapid onset and predictable recovery, is increasingly recognized as an alternative to midazolam. We performed a systematic review and meta-analysis to assess the safety and efficacy outcomes of remimazolam compared with midazolam in diagnostic upper gastrointestinal endoscopy. A literature search was conducted in PubMed, Scopus, the Cochrane Library, and Web of Science from database inception to December 2025. Randomized controlled trials (RCTs) and non-randomized comparative studies were eligible. Forest plots were constructed using mean difference (MD) for continuous outcomes, and risk ratio (RR) for dichotomous outcomes using a random-effects model. heterogeneity was quantified using I

Indexed as

MidazolamRemimazolamSedationUpper gastrointestinal endoscopy

Identifiers

PMID42604873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.